Terminal room disinfection: how much BETR can it get?

Affiliations

¹ Department of Pharmacy, Methodist Dallas Medical Center, Dallas, TX 75203, USA. Electronic address: matthewcrotty@mhd.com.
² Department of Infection Prevention and Control, Methodist Dallas Medical Center, Dallas, TX 75203, USA.

Comment

Matthew P Crotty et al. Lancet. 2017.

. 2017 Feb 25;389(10071):765-766.

doi: 10.1016/S0140-6736(16)32412-6. Epub 2017 Jan 17.

¹ Department of Pharmacy, Methodist Dallas Medical Center, Dallas, TX 75203, USA. Electronic address: matthewcrotty@mhd.com.
² Department of Infection Prevention and Control, Methodist Dallas Medical Center, Dallas, TX 75203, USA.

No abstract available

Comment on

Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.
Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, Blocker M, Becherer P, Schwab JC, Knelson LP, Lokhnygina Y, Rutala WA, Kanamori H, Gergen MF, Sexton DJ; CDC Prevention Epicenters Program. Anderson DJ, et al. Lancet. 2017 Feb 25;389(10071):805-814. doi: 10.1016/S0140-6736(16)31588-4. Epub 2017 Jan 17. Lancet. 2017. PMID: 28104287 Free PMC article. Clinical Trial.